RecruitingNot ApplicableNCT06852352

An Exploratory Study to Confirm Efficacy of Modified Deep Cervical Lymphovenous Anastomosis (LVA) in Alzheimer's Disease/ Parkinson's Disease

A Prospective, Single-center, Single-arm, Exploratory, 24-Month Study to Confirm Efficacy of Modified Deep Cervical Lymphovenous Anastomosis (LVA) in Subjects With Alzheimer's Disease/ Parkinson's Disease


Sponsor

Zhejiang Provincial People's Hospital

Enrollment

160 participants

Start Date

Feb 28, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Alzheimer's disease (AD) and Parkinson's disease (PD) are characterized by pathological protein accumulation in the brain-Aβ/tau in AD and α-synuclein in PD. Recent studies have indicated that age-related lymphatic vessel atrophy compromises the metabolic clearance capacity of meningeal lymphatic vessels, potentially disrupting the equilibrium between production and clearance of Aβ/α-synuclein, ultimately leading to pathological accumulation of these proteins within the brain. Deep cervical lymphovenous anastomosis (LVA), a surgical technique proven effective in restoring lymphatic drainage in lymphedema, may enhance clearance of neurotoxic proteins by improving cervical lymphatic outflow. This project aims to evaluate the efficacy of modified deep cervical LVA in treating AD and PD, establishing a novel therapeutic strategy to modify disease progression and improve quality of life in neurodegenerative disorders, additionally offering the pathogenic mechanisms underlying neurodegenerative disorders.


Eligibility

Min Age: 50 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study tests a new surgical procedure — a small operation on lymphatic vessels in the neck — to see if it can improve symptoms in people with Alzheimer's disease or Parkinson's disease by helping the brain clear waste more effectively. **You may be eligible if (Alzheimer's):** - You are between 50 and 75 years old - You have mild memory loss or early dementia caused by Alzheimer's disease - You have a positive amyloid brain scan - You are in a stable enough condition for minor surgery **You may be eligible if (Parkinson's):** - You are between 50 and 80 years old - You have been diagnosed with Parkinson's disease for 2–5 years - You are in an early to moderate stage of the disease **You may NOT be eligible if:** - You have contraindications to MRI scans, PET scans, or lumbar puncture - You have serious heart, lung, kidney, or liver disease - You have poorly controlled thyroid problems, high blood pressure, or active infections (including HIV) - You have a history of significant bleeding disorders or recent brain injury - You have severe psychiatric illness or recent substance abuse - You are currently enrolled in another clinical trial Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREModified deep cervical Lymphatic-Venous Anastomosis

Deep cervical lymph-vein anastomosis surgery, connecting deep cervical lymph input vein vessels to enhance glymphatic-mediated protein clearance


Locations(1)

Zhejiang Provincial People's Hospital

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06852352


Related Trials